Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure. [electronic resource]
Producer: 20040420Description: 1968 p. digitalISSN:- 0006-4971
- Aminoglycosides -- pharmacology
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antigens, CD -- biosynthesis
- Antigens, Differentiation, Myelomonocytic -- biosynthesis
- Child
- Child, Preschool
- Female
- Gemtuzumab
- Hematopoietic Stem Cell Transplantation
- Hepatic Veno-Occlusive Disease -- prevention & control
- Humans
- Infant
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Platelet Aggregation Inhibitors -- pharmacology
- Polydeoxyribonucleotides -- pharmacology
- Recurrence
- Regression Analysis
- Remission Induction
- Sialic Acid Binding Ig-like Lectin 3
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.